Healthcare Industry News Weekly Wrap-Up: October 31, 2024
// Biotech and Pharma Therapeutics Astellas doesn’t see eye to eye with Europe on geographic atrophy drug Izervay October 28, 2024 / Astellas Izervay Europe Approval / Apellis Syfovre ChallengesAstellas has withdrawn its European application for Izervay in geographic atrophy...